Jacobson Pharma Corporation (2633.HK) Stock Price
Jacobson Pharma Corporation Price
Revenue has compounded at 4.5% per year over the past 12 years to 1.57 B HKD. Earnings per share have grown at 3.6% per year over the last 12 years. Jacobson Pharma Corporation's net margin stands at 19.2%, up from 11.1% several years earlier. Jacobson Pharma Corporation currently offers a dividend yield of about 10.48%. The payout ratio is around 49% of earnings. The dividend has grown at 13.6% per year over the past 9 years. Analysts set a median price target of 2.58 HKD, implying 177.5% above the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
Jacobson Pharma Corporation stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Jacobson Pharma Corporation business model & stock analysis
Frequently asked questions about Jacobson Pharma Corporation
Analysts currently set an average price target of 2.58 HKD for the Jacobson Pharma Corporation stock (median: 2.58 HKD), implying +176.0 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the Jacobson Pharma Corporation stock: 6 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Jacobson Pharma Corporation share trades at 0.11 EUR (0.93 HKD).
The revenue of Jacobson Pharma Corporation is 1.57 B HKD. This figure is based on current financial data and reflects the company's business performance.
The profit of Jacobson Pharma Corporation is 301.62 M HKD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Jacobson Pharma Corporation is currently 6.17. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Jacobson Pharma Corporation stock.
The price-to-sales ratio (P/S) of Jacobson Pharma Corporation is currently 1.18. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Jacobson Pharma Corporation stock.
The Eulerpool Quality Score for Jacobson Pharma Corporation is 5/10.
The ISIN of Jacobson Pharma Corporation is KYG677291067. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Jacobson Pharma Corporation is 2633.HK. The ticker symbol is used to trade Jacobson Pharma Corporation shares on the stock exchange.
Jacobson Pharma Corporation stock
Jacobson Pharma Corporation Peer Group
Jacobson Pharma Corporation FIGI
All fundamentals and in-depth analysis of Jacobson Pharma Corporation
Our stock analysis for Jacobson Pharma Corporation stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jacobson Pharma Corporation. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.